Trademark Attorney / Law Firm

Jonathan B. Thielbar – Trademark Portfolio

Jonathan B. Thielbar specializes in Class 5 (Pharmaceuticals) trademark filings before the United States Patent and Trademark Office (USPTO), with 3 of 5 total filings concentrated in this category. The practice also covers Class 35 (Advertising & Business) along with 4 other Nice Classification classes. Currently, 1 trademark is registered.

5 Total Trademarks
Loading...
By Date
By Name
Filter by Class:

Practice Areas by Trademark Class

Jonathan B. Thielbar's trademark practice covers 4 Nice Classification classes, representing the range of industries and goods/services handled in their USPTO filings.

5
Pharmaceuticals (3 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

35
Advertising & Business (1 filing)

Advertising; business management; business administration; office functions

42
Computer & Scientific (1 filing)

Scientific and technological services; industrial analysis and research services

44
Medical Services (1 filing)

Medical services; veterinary services; hygienic and beauty care for human beings or animals

Frequently Asked Questions

How many trademark applications has Jonathan B. Thielbar filed?

Jonathan B. Thielbar has filed 5 trademark applications with the United States Patent and Trademark Office (USPTO). Of these, 1 registered, 4 cancelled.

What trademark classes does Jonathan B. Thielbar specialize in?

Jonathan B. Thielbar has filed trademarks across 4 Nice Classification classes. The most common practice areas include Class 5 (Pharmaceuticals), Class 35 (Advertising & Business), Class 42 (Computer & Scientific), Class 44 (Medical Services). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What is Jonathan B. Thielbar's trademark registration success rate?

Jonathan B. Thielbar has a 20% trademark registration rate, with 1 out of 5 resolved applications resulting in successful registration. Currently, 0 applications are pending review.